# Nuclide record alzheimers-disease (indication). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/indications/alzheimers-disease/>
  a schema:MedicalCondition ;
  nuclide:kind "indication" ;
  schema:identifier "alzheimers-disease" ;
  schema:name "Alzheimer's disease"@en ;
  schema:description "The most common cause of dementia, in which sticky amyloid protein and tangled tau protein build up in the brain and damage memory and thinking over years."@en ;
  schema:url <https://nuclide.cc/indications/alzheimers-disease/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://jnm.snmjournals.org/content/early/2025/01/07/jnumed.124.268756>, <https://investor.lilly.com/news-releases/news-release-details/fda-approves-updated-label-lillys-amyvid-florbetapir-f-18> ;
  nuclide:tag "neurology", "dementia" ;
  nuclide:related <https://nuclide.cc/drugs/f-18-florbetapir/>, <https://nuclide.cc/drugs/f-18-flutemetamol/>, <https://nuclide.cc/drugs/f-18-florbetaben/>, <https://nuclide.cc/drugs/f-18-flortaucipir/>, <https://nuclide.cc/drugs/f-18-fdg-brain/> .